-
1
-
-
0018757883
-
Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography
-
doi:10.1056/ NEJM197902083000603. PMID:759880
-
Alexander, J., Dainiak, N., Berger, H.J., Goldman, L., Johnstone, D., Reduto, L., et al. 1979. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N. Engl. J. Med. 300(6): 278-283. doi:10.1056/ NEJM197902083000603. PMID:759880.
-
(1979)
N. Engl. J. Med
, vol.300
, Issue.6
, pp. 278-283
-
-
Alexander, J.1
Dainiak, N.2
Berger, H.J.3
Goldman, L.4
Johnstone, D.5
Reduto, L.6
-
2
-
-
4544302695
-
Anti-oxidants and apoptosis: Attenuation of doxorubicin induced cardiomyopathy by carvedilol
-
doi:10.1016/j.yjmcc.2004.07.001. PMID:15380672
-
Armstrong, S.C. 2004. Anti-oxidants and apoptosis: Attenuation of doxorubicin induced cardiomyopathy by carvedilol. J. Mol. Cell. Cardiol. 37(4): 817-821. doi:10.1016/j.yjmcc.2004.07.001. PMID:15380672.
-
(2004)
J. Mol. Cell. Cardiol
, vol.37
, Issue.4
, pp. 817-821
-
-
Armstrong, S.C.1
-
3
-
-
0018102512
-
Anthracycline cardiomyopathy monitored by morphologic changes
-
PMID:667860
-
Billingham, M.E., Mason, J.W., Bristow, M.R., and Daniels, J.R. 1978. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat. Rep. 62(6): 865-872. PMID:667860.
-
(1978)
Cancer Treat. Rep
, vol.62
, Issue.6
, pp. 865-872
-
-
Billingham, M.E.1
Mason, J.W.2
Bristow, M.R.3
Daniels, J.R.4
-
5
-
-
33845402341
-
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition
-
doi:10.1161/CIRCULATIONAHA.106.635144. PMID:17101852
-
Cardinale, D., Colombo, A., Sandri, M.T., Lamantia, G., Colombo, N., Civelli, M., et al. 2006. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation, 114(23): 2474-2481. doi:10.1161/CIRCULATIONAHA.106.635144. PMID:17101852.
-
(2006)
Circulation
, vol.114
, Issue.23
, pp. 2474-2481
-
-
Cardinale, D.1
Colombo, A.2
Sandri, M.T.3
Lamantia, G.4
Colombo, N.5
Civelli, M.6
-
6
-
-
0026610881
-
Humanization of an anti-p185HER2 antibody for human cancer therapy
-
doi:10.1073/pnas.89.10. 4285. PMID:1350088
-
Carter, P., Presta, L., Gorman, C.M., Ridgway, J.B., Henner, D., Wong, W.L., et al. 1992. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 89(10): 4285-4289. doi:10.1073/pnas.89.10. 4285. PMID:1350088.
-
(1992)
Proc. Natl. Acad. Sci. U.S.A
, vol.89
, Issue.10
, pp. 4285-4289
-
-
Carter, P.1
Presta, L.2
Gorman, C.M.3
Ridgway, J.B.4
Henner, D.5
Wong, W.L.6
-
7
-
-
79955069468
-
Chemotherapy-induced cardiotoxicity: Role of the tissue Doppler in the early diagnosis of left ventricular dysfunction
-
doi:10.1097/CAD.0b013e3283443704. PMID:21301318
-
Di Lisi, D., Bonura, F., Macaione, F., Peritore, A., Meschisi, M., Cuttitta, F., et al. 2011. Chemotherapy-induced cardiotoxicity: role of the tissue Doppler in the early diagnosis of left ventricular dysfunction. Anticancer Drugs, 22(5):468-472. doi:10.1097/CAD.0b013e3283443704. PMID:21301318.
-
(2011)
Anticancer Drugs
, vol.22
, Issue.5
, pp. 468-472
-
-
Di, L.D.1
Bonura, F.2
Macaione, F.3
Peritore, A.4
Meschisi, M.5
Cuttitta, F.6
-
8
-
-
84874320403
-
Echocardiography and vascular ultrasound: New developments and future directions
-
doi:10.1016/j.cjca.2012.11.001. PMID:23333166
-
Ducas, R., Tsang, W., Chong, A.A., Jassal, D.S., Lang, R.M., Leong-Poi, H., and Chan, K.L. 2013. Echocardiography and vascular ultrasound: new developments and future directions. Can. J. Cardiol. 29(3): 304-316. doi:10.1016/j.cjca.2012.11.001. PMID:23333166.
-
(2013)
Can. J. Cardiol
, vol.29
, Issue.3
, pp. 304-316
-
-
Ducas, R.1
Tsang, W.2
Chong, A.A.3
Jassal, D.S.4
Lang, R.M.5
Leong-Poi, H.6
Chan, K.L.7
-
9
-
-
84856636292
-
Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG, doi:10.1016/S0140-6736(11)61625-5. PMID:22152853
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG); Peto, R., Davies, C., Godwin, J., Gray, R., Pan, H.C., Clarke, M., et al. 2012. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet, 379(9814): 432-444. doi:10.1016/S0140-6736(11)61625-5. PMID:22152853.
-
(2012)
Lancet
, vol.379
, Issue.9814
, pp. 432-444
-
-
Peto, R.1
Davies, C.2
Godwin, J.3
Gray, R.4
Pan, H.C.5
Clarke, M.6
-
10
-
-
43849094005
-
Cardiotoxicity profile of trastuzumab
-
doi:10.2165/00002018-200831060-00002. PMID:18484781
-
Ewer, S.M., and Ewer, M.S. 2008. Cardiotoxicity profile of trastuzumab. Drug Saf. 31(6): 459-467. doi:10.2165/00002018-200831060-00002. PMID:18484781.
-
(2008)
Drug Saf
, vol.31
, Issue.6
, pp. 459-467
-
-
Ewer, S.M.1
Ewer, M.S.2
-
11
-
-
40949103615
-
Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
-
doi:10.1186/1532- 429X-10-5. PMID:18272009
-
Fallah-Rad, N., Lytwyn, M., Fang, T., Kirkpatrick, I., and Jassal, D.S. 2008. Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy. J. Cardiovasc. Magn. Reson. 10: 5. doi:10.1186/1532- 429X-10-5. PMID:18272009.
-
(2008)
J. Cardiovasc. Magn. Reson
, vol.10
, pp. 5
-
-
Fallah-Rad, N.1
Lytwyn, M.2
Fang, T.3
Kirkpatrick, I.4
Jassal, D.S.5
-
12
-
-
79957576807
-
The utility of cardiac biomarkers, tissue velocity and strain imaging and cardiac MRI in predicting early left ventricular dysfunction in patients with HER-2 positive breast cancer treated with adjuvant trastuzumab therapy
-
doi:10.1016/j.jacc.2010.11.063. PMID: 21616287
-
Fallah-Rad, N., Walker, J.R., Wassef, A., Lytwyn, M., Bohonis, S., Fang, T., et al. 2011. The utility of cardiac biomarkers, tissue velocity and strain imaging and cardiac MRI in predicting early left ventricular dysfunction in patients with HER-2 positive breast cancer treated with adjuvant trastuzumab therapy. J. Am. Coll. Cardiol. 57(22): 2263-2270. doi:10.1016/j.jacc.2010.11.063. PMID: 21616287.
-
(2011)
J. Am. Coll. Cardiol
, vol.57
, Issue.22
, pp. 2263-2270
-
-
Fallah-Rad, N.1
Walker, J.R.2
Wassef, A.3
Lytwyn, M.4
Bohonis, S.5
Fang, T.6
-
13
-
-
0029964861
-
Review of tests for monitoring doxorubicin-induced cardiomyopathy
-
doi:10.1159/000227621. PMID:8960141
-
Ganz, W.I., Sridhar, K.S., Ganz, S.S., Gonzalez, R., Chakko, S., and Serafini, A. 1996. Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology, 53(6): 461-470. doi:10.1159/000227621. PMID:8960141.
-
(1996)
Oncology
, vol.53
, Issue.6
, pp. 461-470
-
-
Ganz, W.I.1
Sridhar, K.S.2
Ganz, S.S.3
Gonzalez, R.4
Chakko, S.5
Serafini, A.6
-
14
-
-
2342591455
-
The discovery of receptor tyrosine kinases: Targets for cancer therapy
-
doi:10.1038/nrc1360
-
Gschwind, A., Fischer, O.M., and Ullrich, A. 2004. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer, 4(5): 361-370. doi:10.1038/nrc1360.
-
(2004)
Nat. Rev. Cancer
, vol.4
, Issue.5
, pp. 361-370
-
-
Gschwind, A.1
Fischer, O.M.2
Ullrich, A.3
-
15
-
-
58149250715
-
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2-positive breast cancer (Short-HER Trial; NCT00629278)
-
doi:10.3816/CBC.2008.n.056. PMID:18952561
-
Guarneri, V., Frassoldati, A., Bruzzi, P., D'Amico, R., Belfiglio, M., Molino, A., et al. 2008. Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2-positive breast cancer (Short-HER Trial; NCT00629278). Clin. Breast Cancer, 8(5): 453-456. doi:10.3816/CBC.2008.n.056. PMID:18952561.
-
(2008)
Clin. Breast Cancer
, vol.8
, Issue.5
, pp. 453-456
-
-
Guarneri, V.1
Frassoldati, A.2
Bruzzi, P.3
D'amico, R.4
Belfiglio, M.5
Molino, A.6
-
16
-
-
70349337359
-
Trastuzumabinduced cardiomyopathy: Not as benign as it looks? A retrospective study
-
doi:10.1016/j.cardfail.2009.04.011. PMID:19786263
-
Guglin, M., Hartlage, G., Reynolds, C., Chen, R., and Patel, V. 2009. Trastuzumabinduced cardiomyopathy: not as benign as it looks? A retrospective study. J. Card. Fail. 15(8): 651-657. doi:10.1016/j.cardfail.2009.04.011. PMID:19786263.
-
(2009)
J. Card. Fail
, vol.15
, Issue.8
, pp. 651-657
-
-
Guglin, M.1
Hartlage, G.2
Reynolds, C.3
Chen, R.4
Patel, V.5
-
17
-
-
0032915392
-
Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
-
doi:10.1016/S0955-0674(99)80024-6. PMID:10209149
-
Hackel, P.O., Zwick, E., Prenzel, N., and Ullrich, A. 1999. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 11(2): 184-189. doi:10.1016/S0955-0674(99)80024-6. PMID:10209149.
-
(1999)
Curr. Opin. Cell Biol
, vol.11
, Issue.2
, pp. 184-189
-
-
Hackel, P.O.1
Zwick, E.2
Prenzel, N.3
Ullrich, A.4
-
18
-
-
67650351539
-
Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab
-
doi:10.1016/j. ahj.2009.05.031. PMID:19619708
-
Hare, J.L., Brown, J.K., Leano, R., Jenkins, C., Woodward, N., and Marwick, T.H. 2009. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am. Heart J. 158(2): 294-301. doi:10.1016/j. ahj.2009.05.031. PMID:19619708.
-
(2009)
Am. Heart J
, vol.158
, Issue.2
, pp. 294-301
-
-
Hare, J.L.1
Brown, J.K.2
Leano, R.3
Jenkins, C.4
Woodward, N.5
Marwick, T.H.6
-
19
-
-
77951662997
-
Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: A speckle tracking echocardiographic study
-
doi: 10.1136/hrt.2009.173997. PMID:20424152
-
Ho, E., Brown, A., Barrett, P., Morgan, R.B., King, G., Kennedy, M.J., and Murphy, R.T. 2010. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart, 96(9): 701-707. doi: 10.1136/hrt.2009.173997. PMID:20424152.
-
(2010)
Heart
, vol.96
, Issue.9
, pp. 701-707
-
-
Ho, E.1
Brown, A.2
Barrett, P.3
Morgan, R.B.4
King, G.5
Kennedy, M.J.6
Murphy, R.T.7
-
20
-
-
53449093684
-
Adjuvant trastuzumab therapy for HER2-positive breast cancer
-
doi:10.3816/CBC.2008.n.037. PMID: 18757259
-
Jahanzeb, M. 2008. Adjuvant trastuzumab therapy for HER2-positive breast cancer. Clin. Breast Cancer, 8(4):324-333. doi:10.3816/CBC.2008.n.037. PMID: 18757259.
-
(2008)
Clin. Breast Cancer
, vol.8
, Issue.4
, pp. 324-333
-
-
Jahanzeb, M.1
-
21
-
-
63249107117
-
Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy
-
doi:10.1016/j.echo.2009.01.016. PMID:19269133
-
Jassal, D.S., Han, S.Y., Hans, C., Sharma, A., Fang, T., Ahmadie, R., et al. 2009. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy. J. Am. Soc. Echocardiogr. 22(4): 418-424. doi:10.1016/j.echo.2009.01.016. PMID:19269133.
-
(2009)
J. Am. Soc. Echocardiogr
, vol.22
, Issue.4
, pp. 418-424
-
-
Jassal, D.S.1
Han, S.Y.2
Hans, C.3
Sharma, A.4
Fang, T.5
Ahmadie, R.6
-
22
-
-
33344478381
-
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
-
FinHer Study Investigators doi:10.1056/NEJMoa053028. PMID:16495393
-
Joensuu, H., Kellokumpu-Lehtinen, P.L., Bono, P., Alanko, T., Kataja, V., Asola, R., et al.; FinHer Study Investigators. 2006. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. N. Engl. J. Med. 354(8): 809-820. doi:10.1056/NEJMoa053028. PMID:16495393.
-
(2006)
N. Engl. J. Med
, vol.354
, Issue.8
, pp. 809-820
-
-
Joensuu, H.1
Kellokumpu-Lehtinen, P.L.2
Bono, P.3
Alanko, T.4
Kataja, V.5
Asola, R.6
-
23
-
-
78650177327
-
Ionizing radiation exposure to patients admitted with acute myocardial infarction in the United States
-
doi:10.1161/CIRCULATIONAHA.110.973339. PMID:21060076
-
Kaul, P., Medvedev, S., Hohmann, S.F., Douglas, P.S., Peterson, E.D., and Patel, M.R. 2010. Ionizing radiation exposure to patients admitted with acute myocardial infarction in the United States. Circulation, 122(21): 2160-2169. doi:10.1161/CIRCULATIONAHA.110.973339. PMID:21060076.
-
(2010)
Circulation
, vol.122
, Issue.21
, pp. 2160-2169
-
-
Kaul, P.1
Medvedev, S.2
Hohmann, S.F.3
Douglas, P.S.4
Peterson, E.D.5
Patel, M.R.6
-
24
-
-
0034820943
-
Anthracycline-induced cardiomyopathy
-
doi:10.1016/S0093-7754(01)90193-9. PMID:11552224
-
Keefe, D.L. 2001. Anthracycline-induced cardiomyopathy. Semin. Oncol. 28(4 Suppl. 11): 2-7. doi:10.1016/S0093-7754(01)90193-9. PMID:11552224.
-
(2001)
Semin. Oncol
, vol.28
, Issue.4 SUPPL. 11
, pp. 2-7
-
-
Keefe, D.L.1
-
25
-
-
84860906122
-
Effects of multidisciplinary team working on breast cancer survival: Retrospective, comparative, interventional cohort study of 13 722 women
-
doi:10.1136/bmj.e2718. PMID:22539013
-
Kesson, E.M., Allardice, G.M., George, W.D., Burns, H.J.G., and Morrison, D.S. 2012. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ, 344: e2718. doi:10.1136/bmj.e2718. PMID:22539013.
-
(2012)
BMJ
, vol.344
-
-
Kesson, E.M.1
Allardice, G.M.2
George, W.D.3
Burns, H.J.G.4
Morrison, D.S.5
-
26
-
-
33750959891
-
Threedimensional echocardiography: The benefits of the additional dimension
-
doi:10.1016/j.jacc.2006.07.047. PMID:17112995
-
Lang, R.M., Mor-Avi, V., Sugeng, L., Nieman, P.S., and Sahn, D.J. 2006. Threedimensional echocardiography: the benefits of the additional dimension. J.Am.Coll. Cardiol. 48: 2053-2069. doi:10.1016/j.jacc.2006.07.047. PMID:17112995.
-
(2006)
J. Am. Coll. Cardiol
, vol.48
, pp. 2053-2069
-
-
Lang, R.M.1
Mor-Avi, V.2
Sugeng, L.3
Nieman, P.S.4
Sahn, D.J.5
-
27
-
-
84863723945
-
Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy
-
doi:10.1007/s00392-011-0406-0. PMID:22249492
-
Lange, S.A., Ebner, B., Wess, A., Kögel, M., Gajda, M., Hitschold, T., and Jung, J. 2012. Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy. Clin. Res. Cardiol. 101(6): 415-426. doi:10.1007/s00392-011-0406-0. PMID:22249492.
-
(2012)
Clin. Res. Cardiol
, vol.101
, Issue.6
, pp. 415-426
-
-
Lange, S.A.1
Ebner, B.2
Wess, A.3
Kögel, M.4
Gajda, M.5
Hitschold, T.6
Jung, J.7
-
28
-
-
0015849162
-
A clinicopathologic analysis of adriamycin cardiotoxicity
-
doi:10.1002/1097- 0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2. PMID:4353012
-
Lefrak, E.A., Pitha, J., Rosenheim, S., and Gottlieb, J.A. 1973. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer,32(2): 302-314. doi:10.1002/1097- 0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2. PMID:4353012.
-
(1973)
Cancer
, vol.32
, Issue.2
, pp. 302-314
-
-
Lefrak, E.A.1
Pitha, J.2
Rosenheim, S.3
Gottlieb, J.A.4
-
29
-
-
58149265138
-
Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin)
-
PMID:19178029
-
Machado, V., Cabral, A., Monteiro, P., Gonçalves, L., and Providência, L.A. 2008. Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin). Rev. Port. Cardiol. 27(10): 1277-1296. PMID:19178029.
-
(2008)
Rev. Port. Cardiol
, vol.27
, Issue.10
, pp. 1277-1296
-
-
Machado, V.1
Cabral, A.2
Monteiro, P.3
Gonçalves, L.4
Providência, L.A.5
-
30
-
-
34347389664
-
Cardiotoxicity of trastuzumab in clinical practice
-
doi:10.1056/NEJMc070065. PMID:17611218
-
McArthur, H.L., and Chia, S. 2007. Cardiotoxicity of trastuzumab in clinical practice. N. Engl. J. Med. 357(1): 94-85. doi:10.1056/NEJMc070065. PMID:17611218.
-
(2007)
N. Engl. J. Med
, vol.357
, Issue.1
, pp. 85-94
-
-
McArthur, H.L.1
Chia, S.2
-
31
-
-
0032842634
-
Detection of anthracycline-induced cardiotoxicity
-
doi:10.1053/ctrv.1999.0128. PMID:10448132
-
Meinardi, M.T., van der Graaf, W.T., van Veldhuisen, D.J., Gietema, J.A., de Vries, E.G., and Sleijfer, D.T. 1999. Detection of anthracycline-induced cardiotoxicity. Cancer Treat. Rev. 25(4): 237-247. doi:10.1053/ctrv.1999.0128. PMID:10448132.
-
(1999)
Cancer Treat. Rev
, vol.25
, Issue.4
, pp. 237-247
-
-
Meinardi, M.T.1
van der Graaf, W.T.2
van Veldhuisen, D.J.3
Gietema, J.A.4
de Vries, E.G.5
Sleijfer, D.T.6
-
32
-
-
33748061258
-
Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury
-
doi:10.1093/eurheartj/ehl013. PMID:16717080
-
Neilan, T.G., Jassal, D.S., Perez-Sanz, T.M., Raher, M.J., Pradhan, A.D., Buys, E.S, et al. 2006. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur. Heart J. 27(15): 1868-1875. doi:10.1093/eurheartj/ehl013. PMID:16717080.
-
(2006)
Eur. Heart J
, vol.27
, Issue.15
, pp. 1868-1875
-
-
Neilan, T.G.1
Jassal, D.S.2
Perez-Sanz, T.M.3
Raher, M.J.4
Pradhan, A.D.5
Buys, E.S.6
-
33
-
-
34248573600
-
Managing cardiotoxicity in anthracycline-treated breast cancers
-
doi:10.1517/14740338.6. 3.315. PMID:17480180
-
Ng, R., and Green, M.D. 2007. Managing cardiotoxicity in anthracycline-treated breast cancers. Expert Opin. Drug Saf. 6(3): 315-321. doi:10.1517/14740338.6. 3.315. PMID:17480180.
-
(2007)
Expert Opin. Drug Saf
, vol.6
, Issue.3
, pp. 315-321
-
-
Ng, R.1
Green, M.D.2
-
34
-
-
0035732998
-
Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy
-
doi:10.1046/j.1365-2796.2001.00820.x. PMID:11298849
-
Nousiainen, T., Vanninen, E., Jantunen, E., Puustinen, J., Remes, J., Rantala, A., and Hartikainen, J. 2001. Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy. J. Intern. Med. 249(4): 297-303. doi:10.1046/j.1365-2796.2001.00820.x. PMID:11298849.
-
(2001)
J. Intern. Med
, vol.249
, Issue.4
, pp. 297-303
-
-
Nousiainen, T.1
Vanninen, E.2
Jantunen, E.3
Puustinen, J.4
Remes, J.5
Rantala, A.6
Hartikainen, J.7
-
35
-
-
0034183463
-
New strategies for managing metastatic breast cancer
-
PMID:10853456
-
Olin, J.J., and Muss, H.B. 2000. New strategies for managing metastatic breast cancer. Oncology (Williston Park), 14: 629-641. PMID:10853456.
-
(2000)
Oncology (Williston Park)
, vol.14
, pp. 629-641
-
-
Olin, J.J.1
Muss, H.B.2
-
36
-
-
4644232608
-
Effect of Doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial
-
doi:10.1200/JCO.2004.03.516. PMID:15365066
-
Perez, E.A., Suman, V.J., Davidson, N.E., Kaufman, P.A., Martino, S., Dakhil, S.R., et al. 2004. Effect of Doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. J. Clin. Oncol. 22(18): 3700-3704. doi:10.1200/JCO.2004.03.516. PMID:15365066.
-
(2004)
J. Clin. Oncol
, vol.22
, Issue.18
, pp. 3700-3704
-
-
Perez, E.A.1
Suman, V.J.2
Davidson, N.E.3
Kaufman, P.A.4
Martino, S.5
Dakhil, S.R.6
-
37
-
-
26844503270
-
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
-
Herceptin Adjuvant (HERA) Trial Study Team doi:10.1056/NEJMoa052306. PMID:16236737
-
Piccart-Gebhart, M.J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., et al.; Herceptin Adjuvant (HERA) Trial Study Team. 2005. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N. Engl. J. Med. 353(16): 1659-1672. doi:10.1056/NEJMoa052306. PMID:16236737.
-
(2005)
N. Engl. J. Med.
, vol.353
, Issue.16
, pp. 1659-1672
-
-
Piccart-Gebhart, M.J.1
Procter, M.2
Leyland-Jones, B.3
Goldhirsch, A.4
Untch, M.5
Smith, I.6
-
38
-
-
79960691560
-
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101-Breast): A randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI
-
doi:10.1186/1471-2407-11-318. PMID: 21794114
-
Pituskin, E., Haykowsky, M., Mackey, J.R., Thompson, R.B., Ezekowitz, J., Koshman, S., et al. 2011. Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101-Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI. BMC Cancer, 11: 318. doi:10.1186/1471-2407-11-318. PMID: 21794114.
-
(2011)
BMC Cancer
, vol.11
, pp. 318
-
-
Pituskin, E.1
Haykowsky, M.2
Mackey, J.R.3
Thompson, R.B.4
Ezekowitz, J.5
Koshman, S.6
-
39
-
-
50849096058
-
Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: Current experience and future strategies
-
doi:10.1093/annonc/mdn292. PMID:18480068
-
Rayson, D., Richel, D., Chia, S., Jackisch, C., van der Vegt, S., and Suter, T. 2008. Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies. Ann. Oncol. 19(9): 1530-1539. doi:10.1093/annonc/mdn292. PMID:18480068.
-
(2008)
Ann. Oncol
, vol.19
, Issue.9
, pp. 1530-1539
-
-
Rayson, D.1
Richel, D.2
Chia, S.3
Jackisch, C.4
van der Vegt, S.5
Suter, T.6
-
40
-
-
26844536978
-
Trastuzumab plus adjuvant chemotherapy for operable HER2- positive breast cancer
-
doi:10.1056/NEJMoa 052122. PMID:16236738
-
Romond, E.H., Perez, E.A., Bryant, J., Suman, V.J., Geyer, C.E., Jr., Davidson, N.E., et al. 2005. Trastuzumab plus adjuvant chemotherapy for operable HER2- positive breast cancer. N. Engl. J. Med. 353(16): 1673-1684. doi:10.1056/NEJMoa 052122. PMID:16236738.
-
(2005)
N. Engl. J. Med
, vol.353
, Issue.16
, pp. 1673-1684
-
-
Romond, E.H.1
Perez, E.A.2
Bryant, J.3
Suman, V.J.4
Geyer Jr., C.E.5
Davidson, N.E.6
-
41
-
-
79954593490
-
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients
-
doi:10.1016/j.amjcard.2011.01.006. PMID: 21371685
-
Sawaya, H., Sebag, I.A., Plana, J.C., Januzzi, J.L., Ky, B., Cohen, V., et al. 2011. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am. J. Cardiol. 107(9): 1375-1380. doi:10.1016/j.amjcard.2011.01.006. PMID: 21371685.
-
(2011)
Am. J. Cardiol
, vol.107
, Issue.9
, pp. 1375-1380
-
-
Sawaya, H.1
Sebag, I.A.2
Plana, J.C.3
Januzzi, J.L.4
Ky, B.5
Cohen, V.6
-
42
-
-
0032563825
-
Doxorubicin-induced cardiomyopathy
-
doi:10.1056/NEJM199809243391307. PMID:9744975
-
Singal, P.K., and Iliskovic, N. 1998. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339(13): 900-905. doi:10.1056/NEJM199809243391307. PMID:9744975.
-
(1998)
N. Engl. J. Med
, vol.339
, Issue.13
, pp. 900-905
-
-
Singal, P.K.1
Iliskovic, N.2
-
43
-
-
0028275840
-
Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats
-
doi:10.1161/01.CIR.89.6. 2829. PMID:8205698
-
Siveski-Iliskovic, N., Kaul, N., and Singal, P.K. 1994. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation, 89: 2829-2935. doi:10.1161/01.CIR.89.6. 2829. PMID:8205698.
-
(1994)
Circulation
, vol.89
, pp. 2829-2935
-
-
Siveski-Iliskovic, N.1
Kaul, N.2
Singal, P.K.3
-
44
-
-
0028888378
-
Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect
-
doi:10.1161/01.CIR.91.1.10. PMID:7805190
-
Siveski-Iliskovic, N., Hill, M., Chow, D.A., and Singal, P.K. 1995. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation, 91: 10-15. doi:10.1161/01.CIR.91.1.10. PMID:7805190.
-
(1995)
Circulation
, vol.91
, pp. 10-15
-
-
Siveski-Iliskovic, N.1
Hill, M.2
Chow, D.A.3
Singal, P.K.4
-
45
-
-
37049183697
-
Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
-
doi:10.1126/ science.3798106. PMID:3798106
-
Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., and McGuire, W.L. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235(4785): 177-182. doi:10.1126/ science.3798106. PMID:3798106.
-
(1987)
Science
, vol.235
, Issue.4785
, pp. 177-182
-
-
Slamon, D.J.1
Clark, G.M.2
Wong, S.G.3
Levin, W.J.4
Ullrich, A.5
McGuire, W.L.6
-
46
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
-
doi:10.1056/NEJM200103153441101. PMID:11248153
-
Slamon, D.J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., et al. 2001. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344(11): 783-792. doi:10.1056/NEJM200103153441101. PMID:11248153.
-
(2001)
N. Engl. J. Med
, vol.344
, Issue.11
, pp. 783-792
-
-
Slamon, D.J.1
Leyland-Jones, B.2
Shak, S.3
Fuchs, H.4
Paton, V.5
Bajamonde, A.6
-
47
-
-
33845914783
-
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: A randomised controlled trial
-
HERA study team doi:10.1016/S0140-6736(07)60028-2. PMID:17208639
-
Smith, I., Procter, M., Gelber, R.D., Guillaume, S., Feyereislova, A., Dowsett, M., et al.; HERA study team. 2007. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet, 369(9555): 29-36. doi:10.1016/S0140-6736(07)60028-2. PMID:17208639.
-
(2007)
Lancet
, vol.369
, Issue.9555
, pp. 29-36
-
-
Smith, I.1
Procter, M.2
Gelber, R.D.3
Guillaume, S.4
Feyereislova, A.5
Dowsett, M.6
-
48
-
-
0035108975
-
Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy
-
doi:10.1002/jmri.1052. PMID:11241808
-
Strohm, O., Schultz-Menger, J., Pilz, B., Osterziel, K.J., Dietz, R., and Friedrich, M.G. 2001. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J. Magn. Reson. Imaging, 13(3): 367-371. doi:10.1002/jmri.1052. PMID:11241808.
-
(2001)
J. Magn. Reson. Imaging
, vol.13
, Issue.3
, pp. 367-371
-
-
Strohm, O.1
Schultz-Menger, J.2
Pilz, B.3
Osterziel, K.J.4
Dietz, R.5
Friedrich, M.G.6
-
49
-
-
34548531901
-
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
-
doi:10.1200/ JCO.2006.09.1611. PMID:17646669
-
Suter, T.M., Procter, M., van Veldhuisen, D.J., Muscholl, M., Bergh, J., Carlomagno, C., et al. 2007. Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J. Clin. Oncol. 25(25): 3859-3865. doi:10.1200/ JCO.2006.09.1611. PMID:17646669.
-
(2007)
J. Clin. Oncol
, vol.25
, Issue.25
, pp. 3859-3865
-
-
Suter, T.M.1
Procter, M.2
van Veldhuisen, D.J.3
Muscholl, M.4
Bergh, J.5
Carlomagno, C.6
-
50
-
-
84856439776
-
Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer
-
Italian Cardio-Oncologic Network doi:10.1016/j.cardfail.2011.10.015. PMID:22300778
-
Tarantini, L., Cioffi, G., Gori, S., Tuccia, F., Boccardi, L., Bovelli, D., et al.; Italian Cardio-Oncologic Network. 2012. Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer. J. Card. Fail. 18(2): 113-119. doi:10.1016/j.cardfail.2011.10.015. PMID:22300778.
-
(2012)
J. Card. Fail
, vol.18
, Issue.2
, pp. 113-119
-
-
Tarantini, L.1
Cioffi, G.2
Gori, S.3
Tuccia, F.4
Boccardi, L.5
Bovelli, D.6
-
51
-
-
84872033896
-
Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: Application to patients undergoing cancer chemotherapy
-
doi:10.1016/j.yjmcc.2013.02.006, 10.1016/j.jacc.2012.09.035. PMID: 23199515
-
Thavendiranathan, P., Grant, A.D., Negishi, T., Plana, J.C., Popović, Z.B., and Marwick, T.H. 2013. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J. Am. Coll. Cardiol. 61(1): 77-84. doi:10.1016/j.yjmcc.2013.02.006, 10.1016/j.jacc.2012.09.035. PMID: 23199515.
-
(2013)
J. Am. Coll. Cardiol
, vol.61
, Issue.1
, pp. 77-84
-
-
Thavendiranathan, P.1
Grant, A.D.2
Negishi, T.3
Plana, J.C.4
Popović, Z.B.5
Marwick, T.H.6
-
52
-
-
32144438170
-
Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: Comparison with echocardiography
-
PMID:16739356
-
Villani, F., Meazza, R., and Materazzo, C. 2006. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography. Anticancer Res. 26(1B): 797-801. PMID:16739356.
-
(2006)
Anticancer Res
, vol.26
, Issue.1 B
, pp. 797-801
-
-
Villani, F.1
Meazza, R.2
Materazzo, C.3
-
53
-
-
0036467826
-
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer
-
doi:10.1200/JCO.20.3.719. PMID:11821453
-
Vogel, C.L., Cobleigh, M.A., Tripathy, D., Gutheil, J.C., Harris, L.N., Fehrenbacher, L., et al. 2002. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. 20(3): 719-726. doi:10.1200/JCO.20.3.719. PMID:11821453.
-
(2002)
J. Clin. Oncol
, vol.20
, Issue.3
, pp. 719-726
-
-
Vogel, C.L.1
Cobleigh, M.A.2
Tripathy, D.3
Gutheil, J.C.4
Harris, L.N.5
Fehrenbacher, L.6
-
54
-
-
68949121146
-
Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: A retrospective study
-
doi:10.1007/s10549-008-0260-6. PMID:19082707
-
Wadhwa, D., Fallah-Rad, N., Grenier, D., Krahn, M., Fang, T., Ahmadie, R., et al. 2009. Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study. Breast Cancer Res. Treat. 117(2): 357-364. doi:10.1007/s10549-008-0260-6. PMID:19082707.
-
(2009)
Breast Cancer Res. Treat
, vol.117
, Issue.2
, pp. 357-364
-
-
Wadhwa, D.1
Fallah-Rad, N.2
Grenier, D.3
Krahn, M.4
Fang, T.5
Ahmadie, R.6
-
55
-
-
74549224505
-
The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure
-
PMID:20098570
-
Walker, J.R., Singal, P.K., and Jassal, D.S. 2009. The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure. Exp. Clin. Cardiol. 14(3): e62-e67. PMID:20098570.
-
(2009)
Exp. Clin. Cardiol
, vol.14
, Issue.3
-
-
Walker, J.R.1
Singal, P.K.2
Jassal, D.S.3
-
56
-
-
77955294878
-
Role of three-dimensional echocardiography in breast cancer: Comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging
-
doi:10.1200/JCO.2009.26.7294. PMID:20530277
-
Walker, J., Bhullar, N., Fallah-Rad, N., Lytwyn, M., Golian, M., Fang, T., et al. 2010. Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. J. Clin. Oncol. 28(21):3429-3436. doi:10.1200/JCO.2009.26.7294. PMID:20530277.
-
(2010)
J. Clin. Oncol
, vol.28
, Issue.21
, pp. 3429-3436
-
-
Walker, J.1
Bhullar, N.2
Fallah-Rad, N.3
Lytwyn, M.4
Golian, M.5
Fang, T.6
-
57
-
-
33745615786
-
Herceptin (trastuzumab): Adjuvant and neoadjuvant trials
-
PMID:16833172
-
Yaal-Hahoshen, N., and Safra, T. 2006. Herceptin (trastuzumab): adjuvant and neoadjuvant trials. Isr. Med. Assoc. J. 8(6): 416-421. PMID:16833172.
-
(2006)
Isr. Med. Assoc. J
, vol.8
, Issue.6
, pp. 416-421
-
-
Yaal-Hahoshen, N.1
Safra, T.2
-
58
-
-
0034638917
-
Overexpression of ErbB2 in cancer and ErbB2- targeting strategies
-
doi:10.1038/sj.onc.1203972. PMID:11156524
-
Yu, D., and Hung, M.C. 2000. Overexpression of ErbB2 in cancer and ErbB2- targeting strategies. Oncogene, 19(53): 6115-6121. doi:10.1038/sj.onc.1203972. PMID:11156524.
-
(2000)
Oncogene
, vol.19
, Issue.53
, pp. 6115-6121
-
-
Yu, D.1
Hung, M.C.2
-
59
-
-
34248214786
-
Tissue Doppler imaging: A new prognosticator for cardiovascular diseases
-
doi:10.1016/j.jacc.2007.01.078. PMID:17498573
-
Yu, C.M., Sanderson, J.E., Marwick, T.H., and Oh, J.K. 2007. Tissue Doppler imaging: a new prognosticator for cardiovascular diseases. J. Am. Coll. Cardiol. 49(19): 1903-1914. doi:10.1016/j.jacc.2007.01.078. PMID:17498573.
-
(2007)
J. Am. Coll. Cardiol
, vol.49
, Issue.19
, pp. 1903-1914
-
-
Yu, C.M.1
Sanderson, J.E.2
Marwick, T.H.3
Oh, J.K.4
-
60
-
-
80054886881
-
Trastuzumab-induced cardiac dysfunction: A 'dual-hit'
-
PMID: 22065936
-
Zeglinski, M., Ludke, A., Jassal, D.S., and Singal, P.K. 2011. Trastuzumab-induced cardiac dysfunction: A 'dual-hit'. Exp. Clin. Cardiol. 16(3): 70-74. PMID: 22065936.
-
(2011)
Exp. Clin. Cardiol
, vol.16
, Issue.3
, pp. 70-74
-
-
Zeglinski, M.1
Ludke, A.2
Jassal, D.S.3
Singal, P.K.4
|